A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Conditions: Leiomyosarcoma; Soft-tissue Sarcomas Interventions: Drug: Gemcitabine; Drug: Nab-Sirolimus Sponsors: M.D. Anderson Cancer Center; Aadi Bioscience Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials